CAP TODAY/AstraZeneca Webinar: Current and Emerging Biomarkers: Optimizing Testing Strategies in Metastatic NSCLC

Thank you

This live web event has ended. Thank you for attending.

Description

Current and Emerging Biomarkers:
Optimizing Testing Strategies
in Metastatic NSCLC

Why should you register now for this webinar?
Hear national thought leaders discuss the following topics:

Rationale for biomarker testing in patients with mNSCLC
Near-term prospects for changes in biomarker testing recommendations
Strategies to maximize identification of actionable mutations

Brought to you by CAP TODAY
Moderated by Bob McGonnagle, Publisher, CAP TODAY
Presenters: Geoffrey R. Oxnard, MD, and Lauren Ritterhouse, MD, PhD
You will have the opportunity to ask questions of our distinguished presenters.

CAP TODAY does not endorse any of the products or services named within.
©2019 AstraZeneca. All rights reserved. US-34494 Last Updated 11/19

Contributors

Bob McGonnagle

Publisher, CAP TODAY
Geoffrey R. Oxnard, MD

Associate Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Lauren Ritterhouse, MD, PhD

Associate Director, Center for Integrated Diagnostics
Massachusetts General Hospital
Assistant Professor, Pathology, Harvard Medical School